Log in or Sign up for Free to view tailored content for your specialty!
Neuroendocrinology News
Increased oxytocin levels observed in men with hypersexual disorder
Men with hypersexual disorder have higher levels of oxytocin compared with men without the disorder, and behavioral therapy to resolve hypersexual disorder was linked to reductions in oxytocin, according to study data.
Oral acromegaly therapy maintains efficacy for most initial responders at 62 weeks
Nearly all responders to a 26-week course of oral octreotide maintained a biochemical response and symptomatic control of acromegaly at 62 weeks, according to data from the MPOWERED trial.
Log in or Sign up for Free to view tailored content for your specialty!
Unvalidated patient-reported outcome measures limit acromegaly, GH studies
One-third of acromegaly and growth hormone deficiency studies report discrepancies between patient-reported outcomes and biochemical outcomes, with many using unvalidated and poorly reported outcome measures, data from a meta-analysis show.
Endocrine conditions common after pediatric brain tumor treatment
Electronic health records data from a European cohort suggest endocrine secondary effects after pediatric brain tumor treatment develop within 2 years of diagnosis, including pituitary deficiencies, hypothyroidism and obesity.
FDA approves levoketoconazole for Cushing’s syndrome
The FDA approved the steroidogenesis inhibitor levoketoconazole for adults with Cushing’s syndrome for whom surgery is not an option or has not been curative, according to an industry press release.
Multidisciplinary care key in updated pheochromocytoma, paraganglioma guideline
People with metastatic pheochromocytomas and paragangliomas should be closely monitored and undergo routine cross-sectional imaging while also being evaluated by a multidisciplinary team, according to a guideline published in Pancreas.
Updated Cushing’s disease guideline highlights new diagnosis, treatment ‘roadmap’
An updated guideline for the treatment of Cushing’s disease focuses on new therapeutic options and an algorithm for screening and diagnosis, along with best practices for managing disease recurrence.
Neuroendocrine tumors require individualized treatment approach
Patients with neuroendocrine tumors are at greater risk for cancer-associated death compared with death due to other causes; however, mortality rates vary according to tumor site.
Dentists, orthodontists play key role in recognizing facial manifestations of acromegaly
Dentists and orthodontists are uniquely positioned to identify the early facial manifestations of acromegaly, though new survey data suggest more awareness of the condition is needed to improve early diagnoses.
FDA approves first once-weekly injection for pediatric GH deficiency
The FDA approved the first once-weekly formulation of somatropin for children with growth hormone deficiency, according to an industry press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read